Armenia vs Latvia: Access to anti-retroviral drugs, female
Armenia
52.0%
in 2024
Latvia
54.0%
in 2024
Armenia rank
116th
Latvia rank
114th
Access to anti-retroviral drugs, female over time
- Armenia
- Latvia
How they compare
Latvia currently reports 54.0% against 52.0% in Armenia, a difference of 2.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Latvia ahead.
Armenia ranks 116th and Latvia ranks 114th of 141 countries.
Across the 3 decades both report, Armenia averaged higher in 1 and Latvia in 2.
Head to head by decade
| Decade | Armenia | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 2.5% | 0.5% | Latvia |
| 2010s | 27.2% | 20.4% | 6.8% | Armenia |
| 2020s | 48.6% | 51.2% | 2.6% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Armenia or Latvia?
- Latvia, at 54.0% against 52.0% in Armenia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Armenia and Latvia?
- 2.0%, with Latvia ahead.
- How many years of comparable data are there for Armenia and Latvia?
- 25 years are reported by both, from 2000 to 2024.
- How do Armenia and Latvia rank globally for access to anti-retroviral drugs, female?
- Armenia ranks 116th and Latvia ranks 114th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.